ELIZABETH SMITH: Open Payments
NPI 1326744509 · NELLIS AFB, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 11 payments from 6 companies in 2025. Trend: 2023 $279 · 2024 $385 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $182 |
| ABBVIE INC. | 4 | $74 |
| GENZYME CORPORATION | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Madrigal Pharmaceuticals | 1 | $15 |
Products named: TREMFYA, RINVOQ, DUPIXENT, EOHILIA, ZENPEP, REZDIFFRA.
Industry payments across NV — which companies pay providers there.
